COMPARISON OF REAL-WORLD LATER-LINE TREATMENT OUTCOMES IN PATIENTS WITH MICROSATELLITE-INSTABILITY HIGH (MSI-H) VERSUS MICROSATELLITE-STABLE (MSS) METASTATIC COLORECTAL CANCER (MCRC) IN THE UNITED STATES (US)

被引：0
|
作者：
Dixon, M. [1 ]
Gu, J. [1 ]
机构：
[1] Bristol Myers Squibb, Lawrenceville, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO53
引用
收藏
页码：S313 / S314
页数：2
相关论文
共 50 条
  • [1] Clinicopathological features of microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) in Japanese patients.
    Kawazoe, Akihito
    Shitara, Kohei
    Noguchi, Masaaki
    Fukuoka, Shota
    Kuboki, Yasutoshi
    Bando, Hideaki
    Okamoto, Wataru
    Kojima, Takashi
    Doi, Toshihiko
    Ohtsu, Atsushi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [2] REAL-WORLD PATTERNS OF CARE AND OUTCOMES IN PATIENTS WITH MICROSATELLITE-INSTABILITY HIGH TUMORS IN ADVANCED ENDOMETRIAL CANCER IN THE UNITED STATES
    Kelkar, S.
    Corman, S.
    Macahilig, C.
    Prabhu, V.
    Rusibamayila, N.
    Odak, S.
    Orlowski, R.
    Duska, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A118 - A118
  • [3] Clinical outcomes in patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) in the pre-immunotherapy era.
    Zwart, Koen
    van der Baan, Frederieke
    Dixon, Matthew
    Frantz, Bryan
    Punt, Cornelis J. A.
    Koopman, Miriam
    Vink, Geraldine R.
    Roodhart, Jeanine
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 65 - 65
  • [4] Clinical outcome of patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) treated with pembrolizumab.
    Sinicrope, Frank A.
    Chakrabarti, Sakti
    Eiring, Rachel
    Mitchelll, Jessica L.
    Finnes, Heidi D.
    Hubbard, Joleen Marie
    McWilliams, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] SURVIVAL OUTCOMES IN METASTATIC COLORECTAL CANCER (CRC) WITH HIGH-LEVEL MICROSATELLITE INSTABILITY (MSI-H)
    Overman, M. J.
    Kopetz, S.
    Wong, S.
    Tie, J.
    Kosmider, S.
    Jacob, A.
    Vilar, E.
    Gibbs, P.
    Desai, J.
    Tran, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 220 - 221
  • [6] Treatment Patterns and Outcomes of Systemic Therapy for Microsatellite-Stable Metastatic Colorectal Cancer in the United States
    Bekaii-Saab, Tanios S.
    Haller, Daniel G.
    ONCOLOGY-NEW YORK, 2020, 34 (11): : 473 - 474
  • [7] On pembrolizumab (Keytruda) in microsatellite instability-high/mismatch repair deficient (MSI-h/MMRd) metastatic colorectal cancer (mCRC)
    Bekaii-Saab, Tanios S.
    ONCOLOGY-NEW YORK, 2021, 35 (07): : 380 - 380
  • [8] THE HUMANISTIC BURDEN OF MICROSATELLITE INSTABILITY-HIGH (MSI-H) COLORECTAL CANCER (CRC) AND METASTATIC CRC (MCRC) PATIENTS TREATED WITH SUBSEQUENT LINE THERAPY: A SYSTEMATIC REVIEW
    Kohn, C. G.
    Nguyen, E.
    Miller, J. D.
    Nwokeji, E.
    Laurie, M.
    Kamble
    Khan, T.
    Masood, A.
    Korytowsky, B.
    VALUE IN HEALTH, 2017, 20 (09) : A454 - A454
  • [9] Nivolumab ± ipilimumab in treatment (tx) of patients (pts) with metastatic colorectal cancer (mCRC) with and without high microsatellite instability (MSI-H): CheckMate-142 interim results.
    Overman, Michael J.
    Kopetz, Scott
    McDermott, Raymond S.
    Leach, Joseph
    Lonardi, Sara
    Lenz, Heinz-Josef
    Morse, Michael A.
    Desai, Jayesh
    Hill, Andrew
    Axelson, Michael D.
    Moss, Rebecca Anne
    Lin, Chen-Sheng
    Goldberg, Monica
    Andre, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Development of a novel RNA-based microsatellite stable predictive response signature (MSS-PRS) to identify MSS colorectal cancer (CRC) patients with a microsatellite instability-high (MSI-H) molecular phenotype
    Pappan, Kirk
    Mayhew, Gregory
    Shepherd, Jonathan
    Guo, Yuelong
    Beebe, Kirk
    Eisner, Joel
    Milburn, Michael
    CANCER RESEARCH, 2024, 84 (06)
12345